Viewing StudyNCT03170895



Ignite Creation Date: 2024-05-06 @ 10:09 AM
Last Modification Date: 2024-10-26 @ 12:25 PM
Study NCT ID: NCT03170895
Status: COMPLETED
Last Update Posted: 2020-03-30
First Post: 2017-05-26

Brief Title: Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or RelapsedRefractory AML Carrying FLT3-ITD
Sponsor:
Organization: The University of Hong Kong

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 5
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: